Skip to main content
TLPH
NASDAQ Life Sciences

Talphera Flags Going Concern, Cash Drops to $17.1M in Q2 10-Q

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.4
Mkt Cap
$72.66M
52W Low
$0.397
52W High
$1.57
52W Position info
252% above low
Off High info
11% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

TLPH has more than doubled off its 52-week low of $0.397.

Summary

Talphera's Q2 10-Q discloses a going concern warning, $17.1 million in cash, and a $6.9 million net loss for the first half of 2026.


Key Events · Earnings and Guidance · TLPH

  • Going Concern Warning

    Management states substantial doubt about the company's ability to continue as a going concern and expects to need additional capital within 12 months of the filing date.

  • Cash Position Declines

    Cash, cash equivalents and short-term investments totaled $17.1 million as of June 30, 2026, down from $20.4 million at December 31, 2025.

  • Net Loss Widens

    Net loss was $6.9 million for the six months ended June 30, 2026, compared to $6.1 million in the prior-year period, driven by higher R&D expenses for Niyad.

  • Recent Financing

    The third closing of the April 2025 Private Placement on March 13, 2026 raised $4.1 million in gross proceeds through common stock and pre-funded warrants.


Analysis · TLPH · Life Sciences

Talphera's Q2 10-Q reveals a going concern warning and a shrinking cash runway. The company had $17.1 million in cash and investments as of June 30, 2026, down from $20.4 million at year-end, and management states it will need additional capital within the next twelve months. The net loss widened to $6.9 million for the first half of 2026, driven by higher R&D spending on the Niyad clinical program. While the company regained Nasdaq compliance in July, the capital need and going concern language are material risks for a micro-cap life sciences company with no approved products.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TLPH was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $72.7M. The 52-week trading range was $0.40 to $1.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TLPH - Latest Insights

TLPH
Nov 12, 2026, 5:11 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $0.8202 info
Change: -$0.1998 (-20%) info
Market Cap: $42.605M info
TLPH
Nov 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $0.8202 info
Change: -$0.2098 (-20%) info
Market Cap: $42.605M info
TLPH
Nov 12, 2026, 4:01 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.04
Real-time Price: $0.8202 info
Change: -$0.2148 (-21%) info
Market Cap: $42.605M info
TLPH
Aug 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.39
Real-time Price: $0.8202 info
Change: -$0.5698 (-41%) info
Market Cap: $42.605M info
TLPH
Jun 23, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $0.8202 info
Change: -$0.1998 (-20%) info
Market Cap: $42.605M info